References
- SalahZArafehRMaximovVmiR-27a and miR-27a contribute to metastatic properties of osteosarcoma cellsOncotarget2015674920493525749032
- IsakoffMSBielackSSMeltzerPGorlickROsteosarcoma: current treatment and a collaborative pathway to successJ Clin Oncol20153327302926304877
- AndersonPLiposomal muramyl tripeptide phosphatidyl ethanolamine: ifosfamide-containing chemotherapy in osteosarcomaFuture Oncol201523333343
- LuetkeAMeyersPALewisIOsteosarcoma treatment – where do we stand? A state of the art reviewCancer Treat Rev201440452353224345772
- HegyiMSemseiAFJakabZGood prognosis of localized osteosarcoma in young patients treated with limb-salvage surgery and chemotherapyPediatr Blood Cancer201258441521425447
- ZhangHJYangJJLuJPUse of intra-arterial chemotherapy and embolization before limb salvage surgery for osteosarcoma of the lower extremityCardiovasc Intervent Radiol200932467267819296158
- Gaetano BacciMDAlessandraLMDMichelaVMAPrognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapyCancer200610651154116116421923
- KudawaraIAokiYUedaTNeoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in JapanJ Chemother20132514123433444
- BacciGRuggieriPBertoniFLocal and systemic control for osteosarcoma of the extremity treated with neoadjuvant chemotherapy and limb salvage surgery: the Rizzoli experienceOncol Rep200075112910948351
- WhelanJSBielackSSMarinaNEURAMOS CollaboratorsEURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatmentAnn Oncol201526240741425421877
- QadirIUmerMBalochNFunctional outcome of limb salvage surgery with mega-endoprosthetic reconstruction for bone tumorsArch Orthop Trauma Surg201213291227123222592914
- KayalarMSabahDYuceturkGPeroperative flap monitorization with fluorescein in limb salvage operationsEduc Theatre J1976284445448
- FerrariSSerraMAn update on chemotherapy for osteosarcomaExpert Opin Pharmacother20151618272726512909
- RosenGCaparrosBHuvosAGPreoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapyCancer1982496122112306174200
- BacciGFerrariSLonghiANeoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b ProtocolJ Chemother20131319399
- FerrariSRuggieriPCefaloGNeoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1J Clin Oncol201230172112211822564997
- CollinsMWilhelmMConyersRBenefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysisJ Clin Oncol20133118230323669227
- NiuBHWangJJEstablishment of adriamycin resistance cell lines of human osteosarcoma and their biological characteristicsJ Fourth Mil Med Univ20093014144
- FlarakosCCWeiskopfARobinsonMMetabolism of selective 20-Epi-vitamin D3, analogs in rat osteosarcoma UMR-106 cells: isolation and identification of four novel C-1 fatty acid esters of 1α,25-dihydroxy-16-ene-20-Epi-vitamin D3Steroids2017119183028089927
- RochéHFumoleauPSpielmannMSequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 trialJ Clin Oncol20062436566417116941
- BrocatoNBrunoMFAraujoCETreatment of non-small cell lung cancer with ifosfamide (IFO) + 4′-epiadriamycin (EPI) + platinum vs. IFO + EPI: a GETLAC StudyOncology199552124317800338